Cargando…
An in-silico approach to studying a very rare neurodegenerative disease using a disease with higher prevalence with shared pathways and genes: Cerebral adrenoleukodystrophy and Alzheimer’s disease
Cerebral adrenoleukodystrophy (cALD) is a rare neurodegenerative disease characterized by inflammatory demyelination in the central nervous system. Another neurodegenerative disease with a high prevalence, Alzheimer’s disease (AD), shares many common features with cALD such as cognitive impairment a...
Autores principales: | Shim, Yu Jeong, Shin, Min Kyoung, Jung, Junghyun, Koo, Bongseong, Jang, Wonhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553843/ https://www.ncbi.nlm.nih.gov/pubmed/36245924 http://dx.doi.org/10.3389/fnmol.2022.996698 |
Ejemplares similares
-
Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease
por: Signorini, Cinzia, et al.
Publicado: (2022) -
Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014) -
Shared genetic architecture between the two neurodegenerative diseases: Alzheimer’s disease and glaucoma
por: Zheng, Chunwen, et al.
Publicado: (2022) -
Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011) -
Cerebral microinfarct is emergency consequence of Alzheimer's disease: a new insight into development of neurodegenerative diseases
por: Lin, Xinjie, et al.
Publicado: (2022)